Dr. Sherman Hom is the Director of Regulatory Affairs at Medicinal Genomics where he provides recommendations to regulatory officials that are tasked with drafting or modifying microbial testing regulations for cannabis, hemp, and psychedelic mushrooms to ensure safe products for patients and consumers. Before Medicinal Genomics, he was at the New Jersey Department of Health, where he led teams that started the Cannabis Testing Laboratory, the Cannabis Microbial Testing Unit, and created the “All States Medical Cannabis Program Required Testing Compendium”.
At CannMed 23 Sherman will share the latest update to the “All States Cannabis Microbial Required Testing Compendium” to elucidate the present landscape, and identify a consensus set of required tests to lower public health risk.
During our conversation we discuss

How concerned cannabis consumers should be about microbial contamination 
How microbial regulations differ from state to state 
How growers in certain jurisdictions struggle to meet microbial regulations 
The difference between presence-absence and total count microbial tests 
qPCR vs plating
and more

Thanks to This Episode’s Sponsor: Labware
Labware is recognized as the global leader in providing enterprise-scale laboratory automation solutions with over 40 offices across 6 continents. LabWare’s Enterprise Laboratory Platform is a unique and proven suite of product capabilities that encompass LIMS, ELN, LES, method execution, and SDMS in an integrated and enterprise-ready solution.
Learn more at labware.com. 
Additional Resources

Cannabis Microbial Testing Regulations by State [Interactive Tool]
Request an Invitation to CannMed 23
Review the Podcast!
CannMed Archive
CannMed Community Board [Facebook Group]
Healthcare Provider Medical Cannabis Research Study

Ver todos los episodios